AbbVie Inc. ABBV Analyst Ratings

7 ratings from Wall Street analysts · Consensus as of Aug 19, 2026

Analyst Ratings
Buy Avg target $276 showing 7 ratings
Consensus is Buy with a $276.41 average target across 31 analysts (S&P Global, as of 19 August 2026), on a range of $200 to $328. Rows below are the most recent sourced analyst actions, via stockanalysis.com. Consensus as of Aug 19, 2026
ABBV
Reiterated
2026-08-17
Wells Fargo
RatingOverweight
From—
Target$295
From—
Upgrade
2026-08-13
Wolfe Research
RatingBuy
From—
Target$300
From—
Reiterated
2026-08-12
Barclays
RatingOverweight
From—
Target$300
From—
Reiterated
2026-08-10
Evercore ISI
RatingOutperform
From—
Target$246
From—
Reiterated
2026-08-06
Berenberg Bank
RatingBuy
From—
Target$275
From—
Reiterated
2026-08-04
Guggenheim
RatingBuy
From—
Target$261
From—
Reiterated
2026-08-03
Scotiabank
RatingOutperform
From—
Target$280
From—